Beneficial effects of the anti-oestrogen tamoxifen on systemic lupus erythematosus of (NZBxNZW)F1 female mice are associated with specific reduction of IgG3 autoantibodies

Annals of the Rheumatic Diseases

Volumn 62, Issue 4, 2003, Pages 341-346

  Sthoeger, Z M ^a   Zinger, H ^b   Mozes, E ^b  

^a KAPLAN MEDICAL CENTER   (Israel)

^b WEIZMANN INSTITUTE OF SCIENCE   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; IMMUNOGLOBULIN ANTIBODY; IMMUNOGLOBULIN G3; TAMOXIFEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; IMMUNE SYSTEM; IMMUNOFLUORESCENCE; LEUKOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEINURIA; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOCYTE; THROMBOCYTOPENIA;

ANIMALS; ANTIBODIES, ANTINUCLEAR; AUTOIMMUNE DISEASES; CELL NUCLEUS; DNA; ESTROGEN ANTAGONISTS; FEMALE; IMMUNOGLOBULIN G; LUPUS ERYTHEMATOSUS, SYSTEMIC; LUPUS NEPHRITIS; MICE; MICE, INBRED NZB; SURVIVAL RATE; TAMOXIFEN;

EID: 0037378670     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.62.4.341     Document Type: Article

References (42)

1. Raveche ES, Klassen LW, Steinberg AD. Sex differences in formation of anti-T cell antibodies. Nature 1976;263:415-16.
2. Grossman CJ. Interaction between the gonadal steroids and the immune system. Science 1985;227:257-61.
3. Ahmed SA, Penhale WJ, Talal N. Sex hormones, immune response and autoimmune diseases. Am J Pathol 1985;121:531-51.
4. Lahita RG. Sex and age in systemic lupus erythematosus. In: Lahita RG, ed. Systemic lupus erythematosus. New York: Wiley, 1986:523-39.
5. Sthoeger ZM, Chiorazzi N, Lahita RG. Regulation of the immune response by sex hormones. In vitro effects of estradiol and testosterone on pokeweed mitogen induced human B cell differentiation. J Immunol 1988;141:91-8.
6. Inman RD. Immunologic sex differences and the female predominance in systemic lupus erythematosus. Arthritis Rheum 1978;21:849-54.
7. Lahita RG. Sex hormones and systemic lupus erythematosus. Rheum Dis Clin North Am 2000;26:951-68.
8. Cutolo M, Sulli A, Seriolo B, Accardo S, Masi AT. Estrogens, the immune response and aotoimmunity. Clin Exp Rheumatol 1995;13:217-26.
9. Cutolo M, Wilder RL. Different roles of androgens and estrogens in the susceptibility to autoimmune rheumatic diseases. Rheum Dis Clin North Am 2000;26:825-39.
10. Sthoeger ZM, Geltner D, Rider A, Bentwich Z. Systemic lupus erythematosus in 49 Israeli moles. Clin Exp Rheumatol 1987;5:233-40.
11. Rubinian JR, Talal N, Siiteri PK, Sadakian JA. Sex hormone modulation of autoimmunity in NZB/W mice. Arthritis Rheum 1979;22:1162-9.
12. Steinberg AD, Paths JB, Murphy DE, Steinberg RT, Raveche ES. Effects of thymectomy or androgen administration upon the autoimmune disease of MRL/Mp-1pr/1pr mice. J Immunol 1980;125:871-3.
13. Duvic M, Steinberg RD, Klasson LW. Effect of the anti-estrogen nafoxidine on NZB/W autoimmune disease. Arthritis Rheum 1978;1:414-17.
14. Morley KD, Parte A, Hughes GRV. Systemic lupus erythematosus. Two patients treated with donazal. BMJ 1982;284:1431-4.
15. Lahita RG, Chen CY, Monder C, Bardin CW. Experience with 19-nortestosterone in the therapy of systemic lupus erythematosus. Worsened disease after treatment with 19-nortestosterone in men and lack of improvement in women. J Rheumatol 1991;19:547-55.
16. Lahita RG. Dehydroepiandrosterone (DHEA) and lupus erythematosus. Lupus 1997;6:491-3.
17. Mendelovic S, Brocke S, Shoenfeld Y, Ben-Bassat M, Meshorer A, Bakimer R, et al. Induction of a systemic lupus erythematosus-like disease by a common human anti-DNA idiotype. Proc Natl Acad Sci USA 1988;85:260-4.
18. Mendelovic S, Fricke H, Shoenfeld Y, Mozes E. The role of anti- idiotype antibodies in the induction of experimental lupus erythematosus in mice. Eur J Immunol 1989;19:729-34.
19. Sthoeger ZM, Bentwich Z, Zinger H, Mozes E. The beneficial effect of the estrogen antagonist tamoxifen on experimental systemic lupus erythematosus. J Rheumatol 1994;21:2231-8.
20. Dayan M, Zinger H, Kalush F, Mor G, Amir-Zaltzman Y, Kohen F, et al. The beneficial effects of treatment with tamoxifen and anti-estradiol antibody on experimental systemic lupus erythematosus are associated with cytokine modulation. Immunology 1997;90:101-8.
21. Fisher B, Brown A, Walmark N. Prolong tamoxifen therapy for primary breast cancer. Ann Intern Med 1987;106:649-54.
22. Sthoeger ZM, Mozes E, Tartakovsky B. Anticardiolipin antibodies induce pregnancy failure by impairing embryonic implantation. Proc Natl Acad Sci USA 1993;90:6464-7.
23. Haas M. IgG deposits in glomeruli of lupus and nonlupus membranous nephropathies. Am J Kidney Dis 1994;23:358-64.
24. Imai H, Hamai K, Komatuda A, Ohtani H, Miura AB. IgG subclasses in patients with membranoproliferative glomerulonephritis, membranous nephropathy and lupus nephritis. Kidney Int 1997;51:270-6.
25. Eilat E, Dayan M, Zinger H, Mozes E. The mechanism by which a peptide based on complementarity-determining region-1 of a pathogenic anti-DNA auto-Ab ameliorates experimental systemic lupus erythematosus. Proc Natl Acad Sci USA 2001;98:1148-53.
26. Butta A, MacLennan K, Flanders KC, Sacks NPM, Smith H, McKinna A. Induction of transforming growth factor β in human breast cancer in vivo following tamoxifen treatment. Cancer Res 1992;52:4261-4.
27. Matsuzawa A, Mizuno Y, Yamamoto T. Antitumor effect of the antiestrogen tamoxifen on a pregnancy dependent mouse mammary tumor (TPDMT-4). Cancer Res 1981;41:316-24.
28. Steinberg AD, Roths JB, Murphy ED, Steinberg RT, Raveche E. Effects of thymectomy and androgen administration upon the autoimmune disease of MRL/1pr mice. J Immunol 1980;125:871-8.
29. Rubinian JR, Talal N, Greenspan JS, Goodman JR, Siitori PK. Effect of castration and sex hormone treatment on survival, antinucleic acid antibodies and glomerulonephritis in (NZB/NZW)F1 mice. J Exp Med 1978;147:1568-83.
30. Rubinian J, Talal N, Siiteri PK, Sadakia JA. Sex hormone modulation of autoimmunity in NZB/WZW mice. Arthritis Rheum 1979;22:1162-70.
31. Kanda N, Tsuchia T, Tamaki K. Estrogen enhancement of anti-ds-DNA antibody and immunoglobulin G production in peripheral blood mononuclear cells from patients with systemic lupus erythematosus. Arthritis Rheum 1999;42:328-37.
32. Wu WM, Lin BF, Su YC, Suen JL, Chiang BL. Tamoxifen decreases renal inflammation and alleviates disease severity in autoimmune (NZB/W)F1 mice. Scand J Immunol 2000;52:393-400.
33. Dang H, Horbeck RJ. A comparison of anti-DNA antibodies from serum and kidney eluates of (NZBxNZW) F1 mice. J Clin Lab Immunol 1982;9:139-45.
34. 3 production in MRL/1pr mice is responsible for development of lupus nephritis. J Immunol 1991;47:515-19.
35. Fulpius T, Spertini F, Reininger L, Izui S. Immunoglobulin heavy chain constant region determines the pathogenicity of the antigen binding activity of rheumatoid factor. Proc Natl Acad Sci USA 1993;90:2345-9.
36. Takamhashi S, Itoh J, Nose M, Ono M, Yamamoto T, Kyogoku M. Cloning and cDNA sequence analysis of nephritogenic monoclonal antibody derived from MRL/1pr lupus mouse. Mol Immunol 1993;30:177-82.
37. 3 cryoglobulins. Kidney Int 1992;41:65-72.
38. 3 and gp70-antigp70 immune complexes. Cell Immunol 1995;161:207-12.
39. Steinberg EB, Santoro TL, Chused TM, Smathers PA, Steinberg AD. Studies of congenic MRL/1pr xid mice. J Immunol 1982;131:2789-95.
40. Santiago ML, Fossati L, Jacquet C, Muller W, Izui S, Reininger L. Interleukin 4 protects against genetically linked lupus autoimmune syndrome. J Exp Med 1997;185:65-70.
41. Jacob CO, Van Der Meide PH, McDevitt HO. In vivo treatment of (NZBxNZW)F1 lupus-like nephritis with monodonal antibody to interferon. J Exp Med 1987;166:798-803.
42. Takahashi S, Fossati L, Iwamoto M, Merino R, Motta R, Kobayakawa T, et al. Imbalance towards Th1 predominance is associated with acceleration of lupus-like autoimmune syndrome in MRL mice. J Clin Invest 1996;97:1597-604.